BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16895699)

  • 1. [Nephrolithiasis-induced ESRD: frequency, causes and prevention].
    Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
    Nephrol Ther; 2005 Nov; 1(5):301-10. PubMed ID: 16895699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
    Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
    Am J Kidney Dis; 2004 Nov; 44(5):799-805. PubMed ID: 15492945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].
    Jungers P; Joly D; Blanchard A; Courbebaisse M; Knebelmann B; Daudon M
    Nephrol Ther; 2008 Jul; 4(4):231-55. PubMed ID: 18499551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure.
    Nasr SH; Sethi S; Cornell LD; Milliner DS; Boelkins M; Broviac J; Fidler ME
    Nephrol Dial Transplant; 2010 Jun; 25(6):1909-15. PubMed ID: 20064951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.
    Dhondup T; Kittanamongkolchai W; Vaughan LE; Mehta RA; Chhina JK; Enders FT; Hickson LJ; Lieske JC; Rule AD
    Am J Kidney Dis; 2018 Dec; 72(6):790-797. PubMed ID: 30146423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hyperoxaluria: clinical course, diagnosis, and treatment after kidney failure.
    Raju DL; Cantarovich M; Brisson ML; Tchervenkov J; Lipman ML
    Am J Kidney Dis; 2008 Jan; 51(1):e1-5. PubMed ID: 18155525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical approach to adults.
    Monk RD
    Semin Nephrol; 1996 Sep; 16(5):375-88. PubMed ID: 8890394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrolithiasis-related end stage renal disease.
    Pipili C; Kiriakoutzik I; Petychaki F; Koutsovasili A
    Minerva Urol Nefrol; 2013 Jun; 65(2):101-7. PubMed ID: 23703097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A nephrologist's tasks in nephrolithiasis].
    Marangella M
    G Ital Nefrol; 2005; 22(1):16-27. PubMed ID: 15786374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrolithiasis-induced end stage renal disease.
    Ounissi M; Gargueh T; Mahfoudhi M; Boubaker K; Hedri H; Goucha R; Abderrahim E; Ben Hamida F; Ben Abdallah T; El Younsi F; Ben Maiz H; Kheder A
    Int J Nephrol Renovasc Dis; 2010; 3():21-6. PubMed ID: 21694924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of kidney stones as a possible risk factor for chronic kidney disease.
    Vupputuri S; Soucie JM; McClellan W; Sandler DP
    Ann Epidemiol; 2004 Mar; 14(3):222-8. PubMed ID: 15036227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and early detection of oral fungal infection: a cross-sectional controlled study in a group of Swedish end-stage renal disease patients.
    Thorman R; Neovius M; Hylander B
    Scand J Urol Nephrol; 2009; 43(4):325-30. PubMed ID: 19363743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of chronic and end stage kidney disease in patients with nephrolithiasis.
    Shoag J; Halpern J; Goldfarb DS; Eisner BH
    J Urol; 2014 Nov; 192(5):1440-5. PubMed ID: 24929140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parathyroid function in recurrent calcium nephrolithiasis and chronic kidney failure before and after oral calcium loading].
    Ivanov I; Milkov V; Gruev I
    Vutr Boles; 1988; 27(1):106-9. PubMed ID: 3414077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric urinary stone disease--does age matter?
    Kalorin CM; Zabinski A; Okpareke I; White M; Kogan BA
    J Urol; 2009 May; 181(5):2267-71; discussion 2271. PubMed ID: 19296968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of renal and ureteral calculi.
    Knight J
    Alaska Med; 1998; 40(2):27-30. PubMed ID: 9658656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.